- JEWL Dashboard
-
Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Adamas One (JEWL) Financial statements
Company Profile
Sep 2023 | Sep 2022 | ||
---|---|---|---|
Total Revenue | |||
Cost of Revenue | |||
Gross Profit | |||
Gross Profit Margin (%) | |||
R&D Expense | |||
SG&A Expense | |||
Total Operating Expenses | |||
Operating Income or Loss | |||
Operating Margin (%) | |||
Interest Expense | |||
Total Other Income/Expenses | |||
Income Before Tax | |||
Income Tax Expense | |||
Income from Continuing Ops. | |||
Net Income | |||
Net Profit Margin (%) | |||
Net Income Available to Common Shareholders | |||
Basic EPS | |||
Diluted EPS | |||
Basic Average Shares | |||
Diluted Average Shares |
Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | ||
---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||
Cost of Revenue | |||||||||
Gross Profit | |||||||||
Gross Profit Margin (%) | |||||||||
R&D Expense | |||||||||
SG&A Expense | |||||||||
Total Operating Expenses | |||||||||
Operating Income or Loss | |||||||||
Operating Margin (%) | |||||||||
Interest Expense | |||||||||
Total Other Income/Expenses | |||||||||
Income Before Tax | |||||||||
Income Tax Expense | |||||||||
Income from Continuing Ops. | |||||||||
Net Income | |||||||||
Net Profit Margin (%) | |||||||||
Net Income Available to Common Shareholders | |||||||||
Basic EPS | |||||||||
Diluted EPS | |||||||||
Basic Average Shares | |||||||||
Diluted Average Shares |
Sep 2023 | Sep 2022 | ||
---|---|---|---|
Current Assets | |||
Cash & Cash Equivalents | |||
Marketable Securities | |||
Receivables | |||
Inventories | |||
Other Current Assets | |||
Total Current Assets | |||
Non-Current Assets | |||
Marketable Securities | |||
PPE Net | |||
Intangibles inc. Goodwill | |||
Other Non-Current Assets | |||
Total Non-Current Assets | |||
Total Assets | |||
Current Liabilities | |||
Accounts Payable | |||
Deferred Revenues | |||
Debt, Current | |||
Accrued Liabilities | |||
Other Current Liabilities | |||
Total Current Liabilities | |||
Non-Current Liabilities | |||
Deferred Revenues | |||
Debt, Non-Current | |||
Other Non-Current Liabilities | |||
Total Non-Current Liabilities | |||
Total Liabilities | |||
Shareholders' Equity | |||
Common Stock | |||
Additional Paid-In Capital | |||
Retained Earnings | |||
Other Shareholders' Equity | |||
Total Shareholders' Equity | |||
Total Liabilities & Shareholders' Equity |
Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | ||
---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||
Cash & Cash Equivalents | |||||||||
Marketable Securities | |||||||||
Receivables | |||||||||
Inventories | |||||||||
Other Current Assets | |||||||||
Total Current Assets | |||||||||
Non-Current Assets | |||||||||
Marketable Securities | |||||||||
PPE Net | |||||||||
Intangibles inc. Goodwill | |||||||||
Other Non-Current Assets | |||||||||
Total Non-Current Assets | |||||||||
Total Assets | |||||||||
Current Liabilities | |||||||||
Accounts Payable | |||||||||
Deferred Revenues | |||||||||
Debt, Current | |||||||||
Accrued Liabilities | |||||||||
Other Current Liabilities | |||||||||
Total Current Liabilities | |||||||||
Non-Current Liabilities | |||||||||
Deferred Revenues | |||||||||
Debt, Non-Current | |||||||||
Other Non-Current Liabilities | |||||||||
Total Non-Current Liabilities | |||||||||
Total Liabilities | |||||||||
Shareholders' Equity | |||||||||
Common Stock | |||||||||
Additional Paid-In Capital | |||||||||
Retained Earnings | |||||||||
Other Shareholders' Equity | |||||||||
Total Shareholders' Equity | |||||||||
Total Liabilities & Shareholders' Equity |
Sep 2023 | Sep 2022 | ||
---|---|---|---|
Cash Flows from Operating Activities | |||
Net Income | |||
Depreciation & Amortization | |||
Deferred Income Taxes | |||
Stock Based Compensation | |||
Accounts Receivable | |||
Inventory | |||
Accounts Payable | |||
Deferred Revenue | |||
Other Non-Cash | |||
Operating Cash Flow | |||
Cash Flows from Investing Activities | |||
PPE Investments | |||
Net Acquisitions | |||
Purchase of Investments | |||
Sale of Investments | |||
Other Investing Activity | |||
Investing Cash Flow | |||
Cash Flows from Financing Activities | |||
Debt Issued | |||
Proceeds from Debt Repayment | |||
Debt Repayment | |||
Proceeds from Sale of Equity | |||
Equity Repurchased | |||
Dividend Paid | |||
Other Financing Activity | |||
Financing Cash Flow | |||
Cash Position | |||
Beginning Cash Position | |||
End Cash Position | |||
Change in Cash | |||
Free Cash Flow | |||
Operating Cash Flow | |||
Capital Expenditure | |||
Free Cash Flow |
Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | ||
---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||
Net Income | |||||||||
Depreciation & Amortization | |||||||||
Deferred Income Taxes | |||||||||
Stock Based Compensation | |||||||||
Accounts Receivable | |||||||||
Inventory | |||||||||
Accounts Payable | |||||||||
Deferred Revenue | |||||||||
Other Non-Cash | |||||||||
Operating Cash Flow | |||||||||
Cash Flows from Investing Activities | |||||||||
PPE Investments | |||||||||
Net Acquisitions | |||||||||
Purchase of Investments | |||||||||
Sale of Investments | |||||||||
Other Investing Activity | |||||||||
Investing Cash Flow | |||||||||
Cash Flows from Financing Activities | |||||||||
Debt Issued | |||||||||
Proceeds from Debt Repayment | |||||||||
Debt Repayment | |||||||||
Proceeds from Sale of Equity | |||||||||
Equity Repurchased | |||||||||
Dividend Paid | |||||||||
Other Financing Activity | |||||||||
Financing Cash Flow | |||||||||
Cash Position | |||||||||
Beginning Cash Position | |||||||||
End Cash Position | |||||||||
Change in Cash | |||||||||
Free Cash Flow | |||||||||
Operating Cash Flow | |||||||||
Capital Expenditure | |||||||||
Free Cash Flow |